SCHEMBL10922904

SCHEMBL10922904

Cc1nc2scc(C)n2c(=O)c1CCN1CCC(C(=O)c2ccc(F)cc2)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 8/20 0.64
▸ CYP2D6 P10635 4/20 0.64
▸ MAPT P10636 3/20 0.64
▸ TSHR P16473 3/20 0.64
▸ CYP3A4 P08684 3/20 0.64
▸ KDM4E B2RXH2 3/20 0.64
▸ MEN1 O00255 2/20 0.64
▸ HTR1A P08908 2/20 0.64
▸ PKM P14618 2/20 0.64
▸ PMP22 Q01453 2/20 0.64
▸ KMT2A Q03164 2/20 0.64
▸ SMN1; SMN2 Q16637 2/20 0.64
▸ HPGD P15428 1/20 0.64
▸ THPO P40225 1/20 0.64
▸ HTR2A P28223 8/20 0.53
▸ HTR7 P34969 5/20 0.53
▸ HTR6 P50406 5/20 0.53
▸ ALDH1A1 P00352 2/20 0.51
▸ LMNA P02545 2/20 0.51
▸ TP53 P04637 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10925192 0.85 HTR2C (0.64) HTR2CCYP2D6MAPTTSHRCYP3A4
SCHEMBL10846025 0.84 MAPT (0.71) HTR2CCYP2D6MAPTTSHRCYP3A4
SCHEMBL10924080 0.84 HTR2A (0.52) HTR2CCYP2D6MAPTTSHRCYP3A4
SCHEMBL10919317 0.83 HTR2C (0.73) HTR2CCYP2D6MAPTTSHRCYP3A4
SCHEMBL10925664 0.83 HTR2C (0.66) HTR2CCYP2D6MAPTTSHRCYP3A4
SCHEMBL10922449 0.81 HTR2C (0.59) HTR2CCYP2D6MAPTTSHRCYP3A4
SCHEMBL10920489 0.81 HTR2C (0.64) HTR2CCYP2D6MAPTTSHRCYP3A4
SCHEMBL10843518 0.81 MAPT (0.67) HTR2CCYP2D6MAPTTSHRCYP3A4
SCHEMBL10923961 0.80 DRD2 (0.42) HTR2CCYP2D6MAPTTSHRCYP3A4
Setoperone SCHEMBL122185 0.80 HTR2C (0.64) HTR2CCYP2D6MAPTTSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0070053-B1 NOVEL BICYCLIC PYRIMIDIN-5-ONE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1986-04-16 — — EP claimed
US-4443451-A PSYCHOTROPIC, ANTIHISTAMINES, ANTISEROTONINE JANSSEN PHARMACEUTICA N.V. (BE) 1984-04-17 — — US claimed
EP-0070053-A2 Novel bicyclic pyrimidin-5-one derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1983-01-19 — — EP claimed
EP-0070053-B1 NOVEL BICYCLIC PYRIMIDIN-5-ONE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1986-04-16 — — EP disclosed
US-4548938-A PSYCHOTROPIC AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 1985-10-22 — — US disclosed
US-4529727-A Pyrimido[2,1-b][1,3]-thiazines JANSSEN PHARMACEUTICAL, N.V. (BE) 1985-07-16 — — US disclosed
US-4443451-A PSYCHOTROPIC, ANTIHISTAMINES, ANTISEROTONINE JANSSEN PHARMACEUTICA N.V. (BE) 1984-04-17 — — US disclosed
EP-0070053-A2 Novel bicyclic pyrimidin-5-one derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1983-01-19 — — EP disclosed
Send feedback